Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on June 10th. The Formulary decisions from that meeting are summarised in this post.
Formulary News (June 2013)
Posted: Monday, June 17, 2013
Category - Formulary Update
Details the latest Formulary decisions made by ADTC or Medicines Utilisation at their respective meetings.
For a cumulative list of local decisions relating to SMC advice and, where applicable NICE Multiple Technology Appraisals from January 2016 onwards click here
Posted: Monday, June 17, 2013
Category - Formulary Update
Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on June 10th. The Formulary decisions from that meeting are summarised in this post.
Posted: Monday, April 15, 2013
Category - Formulary Update
Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on April 8th 2013. The Formulary decisions from that meeting are summarised in this post.
Posted: Wednesday, February 20, 2013
Category - Formulary Update
Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on February 18th 2013. The Formulary decisions from that meeting are summarised in this post.
Posted: Friday, December 21, 2012
Category - Formulary Update
The latest medicines discussed at ADTC and the agreed Formulary status
Posted: Monday, October 15, 2012
Category - Formulary Update
The latest medicines discussed at ADTC and the agreed Formulary status
Posted: Monday, August 20, 2012
Category - Formulary Update
The latest medicines discussed at ADTC and the agreed Formulary status
Posted: Monday, June 18, 2012
Category - Formulary Update
The latest medicines discussed at ADTC and the agreed Formulary status
Posted: Monday, April 23, 2012
Category - Formulary Update
The latest medicines discussed at ADTC and the agreed Formulary status
Posted: Monday, February 20, 2012
Category - Formulary Update
The latest medicines discussed at ADTC and the agreed Formulary status
Posted: Monday, December 19, 2011
Category - Formulary Update
The latest medicines discussed at ADTC and the agreed Formulary status